T1	PROC 46 91	Estudio abierto, multicéntrico y aleatorizado
T2	PROC 97 131	evaluar la eficacia y la seguridad
#1	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
T3	DISO 166 214	infección crónica por el virus de la hepatitis C
#2	AnnotatorNotes T3	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
T4	CHEM 143 150	ABT-530
#3	AnnotatorNotes T4	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T5	PROC 586 594	tratados
#4	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 612 615	VHC
#5	AnnotatorNotes T6	C0019196; Hepatitis C; Disease or Syndrome
T7	DISO 527 540	infección VHC
#6	AnnotatorNotes T7	C0019196; Hepatitis C; Disease or Syndrome
T8	DISO 548 569	Infección VHC crónica
T9	PROC 620 631	tratamiento
#7	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	CHEM 782 792	excipiente
#8	AnnotatorNotes T10	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T11	CHEM 800 808	fármacos
#9	AnnotatorNotes T11	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T12	DISO 744 756	sensibilidad
T13	DISO 1050 1089	abuso en el consumo de drogas y alcohol
T14	CHEM 632 635	AAD
#10	AnnotatorNotes T14	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
T15	CHEM 1136 1154	fármaco en estudio
#11	AnnotatorNotes T15	C0013230; Investigational New Drugs; Pharmacologic Substance
T16	PROC 1192 1201	protocolo
#12	AnnotatorNotes T16	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T17	PROC 1327 1332	AgHBs
#13	AnnotatorNotes T17	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T18	PROC 1336 1394	anticuerpos frente al virus de la inmunodeficiencia humana
#14	AnnotatorNotes T18	C3714540; HIV Antibody Measurement; Laboratory Procedure
T19	DISO 1417 1420	VHC
#15	AnnotatorNotes T19	C0019196; Hepatitis C; Disease or Syndrome
T20	DISO 1459 1471	co-infección
T21	CHEM 135 142	ABT-493
#16	AnnotatorNotes T21	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T22	DISO 331 379	Infección crónica por el virus de la hepatitis C
#17	AnnotatorNotes T22	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome 
T23	DISO 264 304	Infección por el virus de la Hepatitis C
T24	DISO 653 663	cirróticos
#18	AnnotatorNotes T24	C1623038; Cirrhosis; Disease or Syndrome
T25	PROC 1117 1131	administración
#19	AnnotatorNotes T25	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T26	PROC 1288 1325	antígeno de superficie de hepatitis B
#20	AnnotatorNotes T26	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T27	PROC 1396 1402	Ac VIH
T28	DISO 1498 1501	VHC
#21	AnnotatorNotes T28	C0019196; Hepatitis C; Disease or Syndrome
T29	Date 13 17	2015
T30	LIVB 154 161	adultos
#22	AnnotatorNotes T30	C0001675; Adult; Age Group
T31	Duration 176 183	crónica
#23	AnnotatorNotes T31	C0205191; chronic; Temporal Concept
T32	LIVB 191 214	virus de la hepatitis C
#24	AnnotatorNotes T32	C0220847; hepatitis C virus; Virus
T33	PROC 215 223	genotipo
#25	AnnotatorNotes T33	C1285573; Genotype determination; Laboratory Procedure
T34	LIVB 281 304	virus de la Hepatitis C
#26	AnnotatorNotes T34	C0220847; hepatitis C virus; Virus
T35	Duration 341 348	crónica
#27	AnnotatorNotes T35	C0205191; chronic; Temporal Concept
T36	LIVB 356 379	virus de la hepatitis C
#28	AnnotatorNotes T36	C0220847; hepatitis C virus; Virus
T37	PROC 380 388	genotipo
#29	AnnotatorNotes T37	C1285573; Genotype determination; Laboratory Procedure
T38	LIVB 420 427	Hombres
#30	AnnotatorNotes T38	C0025266; Male population group; Population Group
T39	LIVB 430 437	mujeres
#31	AnnotatorNotes T39	C0043210; Woman; Population Group
T40	Age 438 456	mayores de 18 años
T41	LIVB 537 540	VHC
#32	AnnotatorNotes T41	C0220847; hepatitis C virus; Virus
T42	LIVB 558 561	VHC
#33	AnnotatorNotes T42	C0220847; hepatitis C virus; Virus
T43	Duration 562 569	crónica
#34	AnnotatorNotes T43	C0205191; chronic; Temporal Concept
T44	LIVB 573 582	Pacientes
#35	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Neg_cue 583 585	no
T47	LIVB 640 649	Pacientes
#36	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Neg_cue 650 652	no
T50	LIVB 825 841	Mujer embarazada
#37	AnnotatorNotes T50	C0033011; Pregnant Women; Population Group
T51	PHYS 897 908	amamantando
#38	AnnotatorNotes T51	C0006147; Breast Feeding; Organism Function
T52	LIVB 911 918	hombres
#39	AnnotatorNotes T52	C0025266; Male population group; Population Group
T53	LIVB 927 933	pareja
#40	AnnotatorNotes T53	C0682323; Partner in relationship; Family Group
T54	LIVB 937 956	mujeres embarazadas
#41	AnnotatorNotes T54	C0033011; Pregnant Women; Population Group
T55	LIVB 1015 1023	Paciente
#42	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Date 1038 1046	reciente
T57	Duration 1097 1104	6 meses
T60	LIVB 1211 1223	investigador
#43	AnnotatorNotes T60	C0035173; Research Personnel; Professional or Occupational Group
T61	LIVB 1358 1394	virus de la inmunodeficiencia humana
#44	AnnotatorNotes T61	C0019682; HIV; Virus
T62	LIVB 1399 1402	VIH
#45	AnnotatorNotes T62	C0019682; HIV; Virus
T63	PROC 1408 1420	Genotipo VHC
#46	AnnotatorNotes T63	C1533728; Hepatitis C virus genotype determination; Laboratory Procedure
T65	PROC 1486 1494	genotipo
#47	AnnotatorNotes T65	C1285573; Genotype determination; Laboratory Procedure
T67	PHYS 864 874	embarazada
#48	AnnotatorNotes T67	C0032961; Pregnancy; Organism Function
T68	PHYS 980 991	embarazadas
#49	AnnotatorNotes T68	C0032961; Pregnancy; Organism Function
T46	PHYS 945 956	embarazadas
#50	AnnotatorNotes T46	C0032961; Pregnancy; Organism Function
T49	PHYS 831 841	embarazada
#51	AnnotatorNotes T49	C0032961; Pregnancy; Organism Function
T58	DISO 1314 1325	hepatitis B
#52	AnnotatorNotes T58	C0019163; Hepatitis B; Disease or Syndrome
T59	CHEM 1073 1079	drogas
#53	AnnotatorNotes T59	C0086190; Illicit Drugs; Hazardous or Poisonous Substance
A1	Assertion T5 Negated
A2	Assertion T24 Negated
A3	Population_data T30 Age
A4	Status T5 History_of
A5	Status T9 History_of
A6	Assertion T9 Negated
A7	Status T14 History_of
A8	Assertion T14 Negated
A9	Status T12 History_of
A10	Status T13 History_of
#54	AnnotatorNotes T1	C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity
#55	AnnotatorNotes T23	C0019196; Hepatitis C; Disease or Syndrome
#56	AnnotatorNotes T8	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
#57	AnnotatorNotes T12	C0020517; Hypersensitivity; Pathologic Function
#58	AnnotatorNotes T27	C3714540; HIV Antibody Measurement; Laboratory Procedure
#59	AnnotatorNotes T20	C0275524; Coinfection; Disease or Syndrome 
#60	AnnotatorNotes T56	C0332185; Recent; Temporal Concept
T64	Neg_cue 1167 1174	impedir
T66	Observation 1178 1201	adherencia al protocolo
A11	Assertion T66 Negated
T69	Food 1082 1089	alcohol
#61	AnnotatorNotes T69	C0001967; Alcoholic Beverages; Food
T70	Observation 716 736	amenaza para la vida
#62	AnnotatorNotes T70	C2826244; Life Threatening; Finding
T71	Quantifier_or_Qualifier 757 769	significante
#63	AnnotatorNotes T71	C1546944; Event Seriousness - Significant; Qualitative Concept
A12	Status T71 History_of
R1	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T71	
A13	Status T70 History_of
T72	CONC 706 714	gravedad
#64	AnnotatorNotes T72	C1547227; Severe - Severity of Illness Code; Intellectual Product
A14	Status T72 History_of
R2	Causes Arg1:T32 Arg2:T3	
R3	Has_Duration_or_Interval Arg1:T3 Arg2:T31	
T73	Quantifier_or_Qualifier 215 225	genotipo 1
R4	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T73	
R5	Causes Arg1:T34 Arg2:T23	
T74	Quantifier_or_Qualifier 380 390	genotipo 1
R6	Causes Arg1:T36 Arg2:T22	
R7	Has_Duration_or_Interval Arg1:T22 Arg2:T35	
R8	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T74	
R9	Experiences Arg1:T30 Arg2:T21	
R10	Experiences Arg1:T30 Arg2:T3	
R11	Experiences Arg1:T30 Arg2:T33	
R12	Combined_with Arg1:T21 Arg2:T4	
R13	Has_Age Arg1:T39 Arg2:T40	
R14	Has_Age Arg1:T38 Arg2:T40	
T75	Quantifier_or_Qualifier 541 544	GT1
R15	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T75	
R16	Causes Arg1:T41 Arg2:T7	
T76	PROC 477 486	selección
#65	AnnotatorNotes T76	C0242802; Patient Selection; Research Activity
R17	Overlap Arg1:T40 Arg2:T76	
R18	Has_Duration_or_Interval Arg1:T8 Arg2:T43	
R19	Causes Arg1:T42 Arg2:T8	
R20	Experiences Arg1:T44 Arg2:T5	
R21	Negation Arg1:T45 Arg2:T5	
R22	Experiences Arg1:T44 Arg2:T6	
R23	Experiences Arg1:T44 Arg2:T9	
R24	Causes Arg1:T14 Arg2:T9	
R25	Experiences Arg1:T47 Arg2:T24	
R26	Negation Arg1:T48 Arg2:T24	
R27	Causes Arg1:T10 Arg2:T12	
R28	Causes Arg1:T11 Arg2:T12	
R29	Causes Arg1:T10 Arg2:T70	
R30	Causes Arg1:T11 Arg2:T70	
R31	Experiences Arg1:T50 Arg2:T49	
T77	Observation 848 874	planee quedarse embarazada
#66	AnnotatorNotes T77	C0032992; Pregnancy, Planned; Finding
R32	Before Arg1:T77 Arg2:T67	
T78	PROC 1003 1010	estudio
#67	AnnotatorNotes T78	C0008976; Clinical Trials; Research Activity
T79	PROC 886 893	estudio
#68	AnnotatorNotes T79	C0008976; Clinical Trials; Research Activity
R33	Overlap Arg1:T77 Arg2:T79	
R34	Overlap Arg1:T49 Arg2:T79	
R35	Overlap Arg1:T79 Arg2:T51	
R36	Overlap Arg1:T79 Arg2:T46	
R37	Overlap Arg1:T79 Arg2:T68	
T80	Observation 963 991	planeen quedarse embarazadas
#69	AnnotatorNotes T80	C0032992; Pregnancy, Planned; Finding
R38	Overlap Arg1:T80 Arg2:T78	
R39	Overlap Arg1:T49 Arg2:T78	
R40	Overlap Arg1:T77 Arg2:T78	
R41	Overlap Arg1:T51 Arg2:T78	
R42	Overlap Arg1:T46 Arg2:T78	
R43	Experiences Arg1:T54 Arg2:T46	
R44	Before Arg1:T80 Arg2:T68	
R45	Experiences Arg1:T55 Arg2:T13	
R46	Overlap Arg1:T13 Arg2:T56	
#70	AnnotatorNotes T13	C0740858; Substance abuse problem; Mental or Behavioral Dysfunction | C2106524; combined drug and alcohol abuse; Mental or Behavioral Dysfunction
R47	Causes Arg1:T59 Arg2:T13	
R48	Causes Arg1:T69 Arg2:T13	
R49	Has_Duration_or_Interval Arg1:T13 Arg2:T57	
R50	Before Arg1:T13 Arg2:T25	
R51	Used_for Arg1:T15 Arg2:T25	
R52	Experiences Arg1:T55 Arg2:T25	
R53	Before Arg1:T13 Arg2:T66	
R54	Negation Arg1:T64 Arg2:T66	
R55	Experiences Arg1:T55 Arg2:T66	
T81	Result_or_Value 1228 1263	Resultados de laboratorio positivos
#71	AnnotatorNotes T81	C1948092; positive screening/culture/laboratory results; Finding
R57	Has_Result_or_Value Arg1:T26 Arg2:T81	
R58	Has_Result_or_Value Arg1:T17 Arg2:T81	
T82	PROC 1270 1279	selección
#72	AnnotatorNotes T82	C0242802; Patient Selection; Research Activity
R59	Overlap Arg1:T81 Arg2:T82	
R62	Has_Result_or_Value Arg1:T18 Arg2:T81	
R63	Overlap Arg1:T18 Arg2:T82	
R64	Causes Arg1:T61 Arg2:T81	
R65	Causes Arg1:T58 Arg2:T81	
R66	Causes Arg1:T62 Arg2:T81	
R67	Overlap Arg1:T27 Arg2:T82	
R68	Has_Result_or_Value Arg1:T27 Arg2:T81	
T83	PROC 1437 1446	selección
#73	AnnotatorNotes T83	C0242802; Patient Selection; Research Activity
R69	Overlap Arg1:T63 Arg2:T83	
T84	Quantifier_or_Qualifier 1476 1494	más de un genotipo
R73	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T84	
R75	Overlap Arg1:T83 Arg2:T65	
#74	AnnotatorNotes T66	C2364172; Adherence To Medication Regime; Finding (?)
A15	Experiencer T30 Patient
A16	Experiencer T39 Patient
A17	Experiencer T38 Patient
A18	Experiencer T44 Patient
A19	Experiencer T47 Patient
A20	Experiencer T50 Patient
A21	Status T67 Future
A22	Experiencer T52 Family_member
A23	Experiencer T53 Family_member
A24	Experiencer T54 Patient
A25	Status T68 Future
A26	Experiencer T55 Patient
A27	Experiencer T60 Other
